Fidelity Investments’s CytomX Therapeutics CTMX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $49.1M | Buy |
|
|||||
|
2025
Q2 | $21M | Buy |
|
|||||
|
2025
Q1 | $68.9K | Sell |
|
|||||
|
2024
Q4 | $316K | Buy |
|
|||||
|
2024
Q3 | $335K | Buy |
|
|||||
|
2024
Q2 | $296K | Buy |
|
|||||
|
2024
Q1 | $399K | Sell |
|
|||||
|
2023
Q4 | $876K | Sell |
|
|||||
|
2023
Q3 | $913K | Sell |
|
|||||
|
2023
Q2 | $1.25M | Buy |
|
|||||
|
2023
Q1 | $1.07M | Sell |
|
|||||
|
2022
Q4 | $1.15M | Buy |
|
|||||
|
2022
Q3 | $1.02M | Sell |
|
|||||
|
2022
Q2 | $1.29M | Buy |
|
|||||
|
2022
Q1 | $1.87M | Buy |
|
|||||
|
2021
Q4 | $2.32M | Sell |
|
|||||
|
2021
Q3 | $5.32M | Hold |
|
|||||
|
2021
Q2 | $6.62M | Buy |
|
|||||
|
2021
Q1 | $8.08M | Hold |
|
|||||
|
2020
Q4 | $6.85M | Buy |
|
|||||
|
2020
Q3 | $5.49M | Sell |
|
|||||
|
2020
Q2 | $6.91M | Buy |
|
|||||
|
2020
Q1 | $6.36M | Sell |
|
|||||
|
2019
Q4 | $6.88M | Sell |
|
|||||
|
2019
Q3 | $6.53M | Sell |
|
|||||
|
2019
Q2 | $14.8M | Sell |
|
|||||
|
2019
Q1 | $23M | Sell |
|
|||||
|
2018
Q4 | $89.5M | Sell |
|
|||||
|
2018
Q3 | $125M | Buy |
|
|||||
|
2018
Q2 | $134M | Buy |
|
|||||
|
2018
Q1 | $165M | Buy |
|
|||||
|
2017
Q4 | $122M | Buy |
|
|||||
|
2017
Q3 | $100M | Buy |
|
|||||
|
2017
Q2 | $85.4M | Buy |
|
|||||
|
2017
Q1 | $94.6M | Buy |
|
|||||
|
2016
Q4 | $60M | Buy |
|
|||||
|
2016
Q3 | $85.3M | Buy |
|
|||||
|
2016
Q2 | $55.3M | Buy |
|
|||||
|
2016
Q1 | $69.8M | Buy |
|
|||||
|
2015
Q4 | $113M | Buy |
|